Condition: Myocardial Infarction · Sponsor: Hospices Civils de Lyon
ST-segment elevation myocardial infarction (STEMI) is an acute condition that accounts for 75% of sudden deaths in adults over 35 years of age and more than half of all cases of chronic heart failure. However, the mechanism of myocardial infarction remains poorly understood. At present, there is no national information system for myocardial infarction, as there is for other diseases such as multiple sclerosis (OFSEP cohort). The purpose of this cohort is to enable studies and research projects to be carried out on the descriptive epidemiology of myocardial infarction, monitoring of patients undergoing treatment (safety, efficacy), quality of life and functional consequences of infarction, and research into new biological and imaging prognostic biomarkers. Its general objective is to provide researchers, hospital practitioners, medical interns, academics or industrialists with a quality epidemiological tool for research.
This description comes directly from the study's public registry record.
Thomas BOCHATON, Dr · 04 72 35 75 41 · thomas.bochaton@chu-lyon.fr
Yvonne VARILLON · 04 72 35 69 64 · yvonne.varillon@chu-lyon.fr
Always discuss trial participation with your own doctor first.
| Hospices Civils de Lyon - Hôpital Louis Pradel | Bron, Rhone, France | Recruiting |
| Hospices Civils de Lyon - Hôpital de la Croix Rousse | Lyon, Rhone, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05794022